Triple

T926875
Position Surface form Disambiguated ID Type / Status
Subject Massachusetts General Hospital E20002 entity
Predicate hasFacility P105 FINISHED
Object Massachusetts General Hospital Center for Regenerative Medicine
The Massachusetts General Hospital Center for Regenerative Medicine is a research and clinical center focused on developing stem cell and regenerative therapies to repair and replace damaged tissues and organs.
E111547 NE FINISHED

How this triple was built (4 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Massachusetts General Hospital Center for Regenerative Medicine | Statement: [Massachusetts General Hospital, hasFacility, Massachusetts General Hospital Center for Regenerative Medicine]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: Massachusetts General Hospital Center for Regenerative Medicine
Context triple: [Massachusetts General Hospital, hasFacility, Massachusetts General Hospital Center for Regenerative Medicine]
  • A. Whitehead Institute for Biomedical Research
    The Whitehead Institute for Biomedical Research is an independent, nonprofit research institution affiliated with MIT that is renowned for pioneering work in genetics, genomics, and developmental biology.
  • B. Center for Cellular and Molecular Therapeutics
    The Center for Cellular and Molecular Therapeutics is a research institute specializing in developing gene and cell-based therapies for pediatric and genetic diseases.
  • C. Broad Institute of MIT and Harvard
    The Broad Institute of MIT and Harvard is a leading biomedical and genomic research center known for large-scale collaborative projects that advance understanding of human disease and inform new therapies.
  • D. Cambridge Stem Cell Institute
    The Cambridge Stem Cell Institute is a leading research center at the University of Cambridge dedicated to understanding stem cell biology and translating this knowledge into new treatments for human disease.
  • E. Allen Institute for Cell Science
    The Allen Institute for Cell Science is a research institute dedicated to advancing the understanding of human cells through large-scale, open science approaches and cutting-edge imaging and computational technologies.
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg Description generation gpt-5.1
Instruction
Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: Massachusetts General Hospital Center for Regenerative Medicine
Triple: [Massachusetts General Hospital, hasFacility, Massachusetts General Hospital Center for Regenerative Medicine]
Generated description
The Massachusetts General Hospital Center for Regenerative Medicine is a research and clinical center focused on developing stem cell and regenerative therapies to repair and replace damaged tissues and organs.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07
Target entity: Massachusetts General Hospital Center for Regenerative Medicine
Target entity description: The Massachusetts General Hospital Center for Regenerative Medicine is a research and clinical center focused on developing stem cell and regenerative therapies to repair and replace damaged tissues and organs.
  • A. Whitehead Institute for Biomedical Research
    The Whitehead Institute for Biomedical Research is an independent, nonprofit research institution affiliated with MIT that is renowned for pioneering work in genetics, genomics, and developmental biology.
  • B. Center for Cellular and Molecular Therapeutics
    The Center for Cellular and Molecular Therapeutics is a research institute specializing in developing gene and cell-based therapies for pediatric and genetic diseases.
  • C. Broad Institute of MIT and Harvard
    The Broad Institute of MIT and Harvard is a leading biomedical and genomic research center known for large-scale collaborative projects that advance understanding of human disease and inform new therapies.
  • D. Cambridge Stem Cell Institute
    The Cambridge Stem Cell Institute is a leading research center at the University of Cambridge dedicated to understanding stem cell biology and translating this knowledge into new treatments for human disease.
  • E. Allen Institute for Cell Science
    The Allen Institute for Cell Science is a research institute dedicated to advancing the understanding of human cells through large-scale, open science approaches and cutting-edge imaging and computational technologies.
  • F. None of above. chosen

Provenance (5 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69a493af3dc48190adb7263e6e445ea1 completed March 1, 2026, 7:29 p.m.
NER Named-entity recognition batch_69a4b32c5b508190a570c94a6647ba70 completed March 1, 2026, 9:44 p.m.
NED1 Entity disambiguation (via context triple) batch_69a826dc111881908f4e2a0914eb2202 completed March 4, 2026, 12:34 p.m.
NEDg Description generation batch_69a84d39b3b881909ba8d1c4a4757ede completed March 4, 2026, 3:18 p.m.
NED2 Entity disambiguation (via description) batch_69a84dbeef6c81908dd6593722dfb52b completed March 4, 2026, 3:20 p.m.
Created at: March 1, 2026, 7:40 p.m.